Chew S L, Lavender P, Clark A J, Ross R J
Department of Endocrinology, St. Bartholomew's Hospital, London, United Kingdom.
Endocrinology. 1995 May;136(5):1939-44. doi: 10.1210/endo.136.5.7720641.
An alternatively spliced transcript of the human insulin-like growth factor-I (IGF-I) gene is described. The transcript was identified in human liver RNA by reverse transcriptase-polymerase chain reaction, cloning, and sequencing. It contained IGF-I exons 3 and 4, 49 basepairs of exon 5, then exon 6 (exon 4-5-6). The 5'-donor site at the exon 5-6 junction was a cryptic 5'-donor splice site (IGF633). The 3'-acceptor site of the splice was the usual intron-exon 6 junction. A second pair of primers across the exon 5-exon 6 junction was used to confirm the presence of the transcript by reverse transcriptase-polymerase chain reaction. Cloning and sequencing this second fragment confirmed the presence of this splice in human liver. The exon 4-5-6 transcript was quantified at about 10% relative to the exon 4-6 transcript in human livers (n = 7 subjects), but was not detected in other tissues. The exon 4-5-6 transcript was found in cultured human hepatoma HepG2 cells and increased, relative to exon 4-6 transcripts, in response to GH, but not in cultured human lymphoblast IM-9 cells. The exon 4-5-6 splice predicts a prepro-IGF-I of 158 amino acid residues, with an E-peptide sequence of 24 residues (Ec). The deduced Ec peptide sequence is 73% homologous to the rat Eb-peptide sequence. The predicted final residues of the Ec peptide are frameshifted exon 6 codons ending in an in-frame stop codon. The predicted peptide sequences of Ec and Eb differ at the cleavage site of the Eb-peptide fragment (IBE1), which has been shown to have mitogenic activity. These data suggest that 1) the exon 4-5-6 splice has hepatic tissue expression and occurs by the use of a cryptic 5'-donor consensus splice site (IGF633) in exon 5; 2) exon 4-5-6 can be hormonally regulated in cultured human HepG2 cells; 3) exon 4-5-6 is the human counterpart of the rat IGF-IEb, because the complementary DNA and predicted sequences are homologous; and 4) the production of IBE1 is potentially regulated by alternative splicing.
本文描述了人类胰岛素样生长因子-I(IGF-I)基因的一种可变剪接转录本。通过逆转录聚合酶链反应、克隆和测序,在人肝脏RNA中鉴定出了该转录本。它包含IGF-I的外显子3和4、外显子5的49个碱基对,然后是外显子6(外显子4-5-6)。外显子5-6连接处的5'供体位点是一个隐蔽的5'供体剪接位点(IGF633)。剪接的3'受体位点是内含子-外显子6的常见连接处。使用跨越外显子5-外显子6连接处的第二对引物,通过逆转录聚合酶链反应来确认该转录本的存在。对该第二个片段进行克隆和测序,证实了人肝脏中存在这种剪接。在人肝脏(n = 7名受试者)中,外显子4-5-6转录本的量相对于外显子4-6转录本约为10%,但在其他组织中未检测到。在培养的人肝癌HepG2细胞中发现了外显子4-5-6转录本,相对于外显子4-6转录本,其在生长激素(GH)刺激下增加,但在培养的人淋巴母细胞IM-9细胞中未增加。外显子4-5-6剪接预测出一个由158个氨基酸残基组成的前胰岛素样生长因子-I,其E肽序列有24个残基(Ec)。推导的Ec肽序列与大鼠Eb肽序列的同源性为73%。Ec肽的预测最终残基是外显子6密码子移码后以框内终止密码子结束。Ec和Eb的预测肽序列在Eb肽片段(IBE1)的切割位点不同,IBE1已被证明具有促有丝分裂活性。这些数据表明:1)外显子4-5-6剪接具有肝脏组织表达,且是通过使用外显子5中的一个隐蔽的5'供体共有剪接位点(IGF633)发生的;2)外显子4-5-6在培养的人HepG2细胞中可受激素调节;3)外显子4-5-6是大鼠IGF-IEb的人类对应物,因为互补DNA和预测序列是同源的;4)IBE1的产生可能受可变剪接的调节。